Last 12 months
Inside the activity.
9 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 1 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 4 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2024 Filed Feb 13, 2024 02:43 UTC |
Klein PatrickChief Administrative Officer
|
GrantNon-Qualified Stock Option · Derivative | 9,593 | $0.00 Strike: $67.02 | $0.00 |
DisclosureSEC source: 0000950170-24-014148 · ownership.xml · derivative · entry 1 Klein Patrick · CIK 0001978037 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,593 Underlying: Common Stock · 9,593 shares Expires 2034-02-08 F1 · derivative.exercise_date: 3,197 shares will vest on February 8, 2025; the remaining 6,396 shares will vest in equal installments on February 8, 2026 and February 8, 2027. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 16:07 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantRestricted Stock Units (Premium) · Derivative | 260 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016353 · ownership.xml · derivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 260 Underlying: Common Stock · 260 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.exercise_date: The restricted stock units vest on February 8, 2025. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.expiration_date: The restricted stock units vest on February 8, 2025. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 16:07 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantRestricted Stock Units (Converted) · Derivative | 868 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016353 · ownership.xml · derivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 868 Underlying: Common Stock · 868 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.exercise_date: The restricted stock units vested on February 8, 2024. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.expiration_date: The restricted stock units vested on February 8, 2024. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 21:08 UTC |
Klein PatrickChief Administrative Officer
|
GrantRestricted Stock Units (Premium) · Derivative | 251 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016355 · ownership.xml · derivative · entry 2 Klein Patrick · CIK 0001978037 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251 Underlying: Common Stock · 251 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.exercise_date: The restricted stock units vest on February 8, 2025. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F4 · derivative.expiration_date: The restricted stock units vest on February 8, 2025. Read SEC document |
| February 08, 2024 Filed Feb 16, 2024 21:08 UTC |
Klein PatrickChief Administrative Officer
|
GrantRestricted Stock Units (Converted) · Derivative | 839 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-016355 · ownership.xml · derivative · entry 1 Klein Patrick · CIK 0001978037 · Chief Administrative Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 839 Underlying: Common Stock · 839 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F2 · derivative.exercise_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.exercise_date: The restricted stock units vested on February 8, 2024. F2 · derivative.expiration_date: The restricted stock units were received in ieu of cash payments to the reporting person under a deferred compensation program applicable to participating employees. Vested restricted stock units may be deferred, in which case, payment will occur according to the elected deferred schedule. F3 · derivative.expiration_date: The restricted stock units vested on February 8, 2024. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · derivative · entry 6 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,795 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,795 shares vested on February 3, 2024. F5 · derivative.expiration_date: 3,795 shares vested on February 3, 2024. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 1,924 | $68.34 | $131,486.16 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 549,415 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 3,795 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,339 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,660 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 1,660 shares vested on February 3, 2024. F5 · derivative.expiration_date: 1,660 shares vested on February 3, 2024. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 946 | $68.34 | $64,649.64 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,768 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 03, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 1,660 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,714 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,116 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · derivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,116 Underlying: Common Stock · 1,116 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,116 shares vested on February 1, 2024; the remaining 1,116 shares will vest on February 1, 2025. F4 · derivative.expiration_date: 1,116 shares vested on February 1, 2024; the remaining 1,116 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 566 | $69.45 | $39,308.70 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 547,544 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 1,116 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011463 · ownership.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 548,110 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 879 Underlying: Common Stock · 879 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 879 shares vested on February 1, 2024; the remaining 879 shares will vest on February 1, 2025. F4 · derivative.expiration_date: 879 shares vested on February 1, 2024; the remaining 879 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 501 | $69.45 | $34,794.45 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,054 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:10 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 879 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011465 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,555 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 1,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · derivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,313 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,313 shares vested on February 1, 2024. F4 · derivative.expiration_date: 1,313 shares vested on February 1, 2024. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 680 | $69.45 | $47,226.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,771 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 1,313 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011469 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,451 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · derivative · entry 3 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 473 Underlying: Common Stock · 473 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 473 shares vested on February 1, 2024; the remaining 474 shares will vest on February 1, 2025. F4 · derivative.expiration_date: 473 shares vested on February 1, 2024; the remaining 474 shares will vest on February 1, 2025. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 169 | $69.45 | $11,737.05 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · nonDerivative · entry 2 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,858 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 20:11 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 473 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-011466 · ownership.xml · nonDerivative · entry 1 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,027 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 12,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · derivative · entry 6 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,094 Underlying: Common Stock · 12,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 12,093 shares vested on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 12,093 shares vested on January 31, 2024; the remaining 12,094 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · derivative · entry 5 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,522 Underlying: Common Stock · 6,761 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 6,761 shares vested on January 31, 2024; the remaining 13,522 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 6,761 shares vested on January 31, 2024; the remaining 13,522 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 4,954 | $68.51 | $339,398.54 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · nonDerivative · entry 4 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 546,994 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 12,093 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · nonDerivative · entry 3 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 551,948 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
Tax withholdingCommon Stock | 2,476 | $68.51 | $169,630.76 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · nonDerivative · entry 2 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 539,855 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:06 UTC |
BRYANT DOUGLAS CDirector · President & CEO
|
GrantCommon Stock | 6,761 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010870 · ownership.xml · nonDerivative · entry 1 BRYANT DOUGLAS C · CIK 0001406652 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 542,331 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,772 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · derivative · entry 6 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,773 Underlying: Common Stock · 6,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 6,772 shares vested on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. F5 · derivative.expiration_date: 6,772 shares vested on January 31, 2024; 3,386 shares will vest on January 31, 2025; and 3,387 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · derivative · entry 5 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,440 Underlying: Common Stock · 3,219 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 3,219 shares vested on January 31, 2024; the remaining 6,440 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 3,219 shares vested on January 31, 2024; the remaining 6,440 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 3,857 | $68.51 | $264,243.07 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 4 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,676 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 6,772 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 3 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,533 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
Tax withholdingCommon Stock | 1,924 | $68.51 | $131,813.24 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 2 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,761 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:07 UTC |
Bujarski Robert JosephEVP & COO
|
GrantCommon Stock | 3,219 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010874 · ownership.xml · nonDerivative · entry 1 Bujarski Robert Joseph · CIK 0001333458 · EVP & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,685 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · derivative · entry 6 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,548 Underlying: Common Stock · 3,547 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: 3,547 shares vested on January 31, 2024; 3,548 shares will vest on January 31, 2025. F6 · derivative.expiration_date: 3,547 shares vested on January 31, 2024; 3,548 shares will vest on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
Exercise / conversionRestricted Stock Units · Derivative | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · derivative · entry 5 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 3,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; the remining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; the remining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 1,806 | $68.51 | $123,729.06 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 4 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,138 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 3,547 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 3 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,944 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
Tax withholdingCommon Stock | 1,946 | $68.51 | $133,320.46 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 2 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,397 F3 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:09 UTC |
Kroll WernerSVP, Research & Development
|
GrantCommon Stock | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010878 · ownership.xml · nonDerivative · entry 1 Kroll Werner · CIK 0001609320 · SVP, Research & Development 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,343 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. F2 · balance_after: The amount of shares beneficially owned following this transaction includes an additional 76 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units (Premium ) · Derivative | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 12 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 204 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units (Converted) · Derivative | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 11 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,020 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F6 · derivative.exercise_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. F6 · derivative.expiration_date: Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating employees and occurred according to the elected deferred schedule. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 3,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 10 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628 Underlying: Common Stock · 3,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F5 · derivative.exercise_date: 3,628 shares vested on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F5 · derivative.expiration_date: 3,628 shares vested on January 31, 2024; the remaining 3,628 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Exercise / conversionRestricted Stock Units · Derivative | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · derivative · entry 9 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,220 Underlying: Common Stock · 1,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. F4 · derivative.exercise_date: 1,610 shares vested on January 31, 2024; the remaining 3,220 shares will vest in equal installments on January 31, 2025 and January 31, 2026. F4 · derivative.expiration_date: 1,610 shares vested on January 31, 2024; the remaining 3,220 shares will vest in equal installments on January 31, 2025 and January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 73 | $68.51 | $5,001.23 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 8 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,554 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 204 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 7 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,627 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 340 | $68.51 | $23,293.40 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 6 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,423 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
GrantCommon Stock | 1,020 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 5 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,763 F1 · shares: Reflects release of restricted stock units that were previously reported on a Form 4. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 20:23 UTC |
Hodges Michelle ASVP, General Counsel
|
Tax withholdingCommon Stock | 1,305 | $68.51 | $89,405.55 |
DisclosureSEC source: 0000950170-24-010895 · ownership.xml · nonDerivative · entry 4 Hodges Michelle A. · CIK 0001833942 · SVP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,743 F2 · shares: Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.